Search for: "Contain-A-Way Inc."
Results 4081 - 4100
of 7,455
Sort by Relevance
|
Sort by Date
23 Nov 2013, 8:34 pm
See Apple Inc. v. [read post]
22 Nov 2013, 5:49 am
A nonexhaustive list of practices defined as `unfair’ or `deceptive’ is contained in Ohio Revised Code § 1345.02(B). . . . [read post]
20 Nov 2013, 4:30 am
Takeda Pharmaceuticals North America, Inc., 2013 U.S. [read post]
19 Nov 2013, 5:57 pm
See Apple Inc. v. [read post]
19 Nov 2013, 1:07 pm
Priceline.com, Inc., 2013 WL 5946069, B242653 (Cal. [read post]
19 Nov 2013, 5:39 am
Casey, 505 U.S. 833 (1992) (federal)--Auto Equity Sales, Inc. v. [read post]
18 Nov 2013, 1:37 pm
Avepoint, Inc. v. [read post]
13 Nov 2013, 1:13 pm
Ortho-McNeil Pharmaceutical, Inc., 2013 U.S. [read post]
13 Nov 2013, 12:16 pm
Entertainment Inc. (7th Cir.) [read post]
13 Nov 2013, 6:30 am
©2013 Amaxx Risk Solutions, Inc. [read post]
11 Nov 2013, 9:23 pm
Jews for Jesus, Inc., 482 U.S. 569 (1987) (stating that an airport’s proposed interpretation of a speech-restricting policy would be unconstitutionally vague, even if an airport were to be treated as a nonpublic forum); International Soc. for Krishna Consciousness, Inc. v. [read post]
11 Nov 2013, 9:09 pm
See Dayton Area Visually Impaired Persons, Inc. v. [read post]
11 Nov 2013, 11:25 am
Supermarkets, Inc. poses the question whether an owner’s constitutional private property rights must give way to an individual’s constitutional right to collect nomination signatures for public office. [read post]
11 Nov 2013, 8:15 am
Wal-Mart Stores, Inc. v. [read post]
11 Nov 2013, 8:14 am
©2013 Amaxx Risk Solutions, Inc. [read post]
8 Nov 2013, 8:37 pm
Time Warner Cable Inc., No. 2012-1425 (Fed. [read post]
7 Nov 2013, 6:30 am
Management and other executives focus on ways to save money on the medical end, by using aggressive management tactics to contain medical exposure. [read post]
5 Nov 2013, 8:09 am
Horton, Inc., v. [read post]
5 Nov 2013, 6:29 am
In support of its position, the union relied on Caterpillar, Inc. v. [read post]
4 Nov 2013, 9:56 pm
”J&J Subsidiary Janssen Pleads Guilty to Misbranding Antipsychotic DrugIn a criminal information filed today in the Eastern District of Pennsylvania, the government charged that, from March 3, 2002, through Dec. 31, 2003, Janssen Pharmaceuticals Inc., a J&J subsidiary, introduced the antipsychotic drug Risperdal into interstate commerce for an unapproved use, rendering the product misbranded. [read post]
